Read the clinical phase ladder without shortcuts
Interpret what each clinical trial phase is designed to answer and what it cannot yet prove.
The move: ask what the phase was designed to decide. Phase 1, Phase 2, Phase 3, and Phase 4 are not just bigger numbers. They are different decision tools. Phase 1 asks whether the product can be given to humans in a controlled way and what dose, exposure, and early safety profile look like. Phase 2 asks whether there is enough efficacy and safety signal in the disease population to justify a larger test. Phase 3 asks whether the product demonstrates treatment benefit in the intended-use population. Phase 4 studies continue safety and effectiveness learning after approval. This prevents claim…
Sign up free — one personalized lesson every day, matched to your role and goals.
Already have an account? Sign in